Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Bolton Medical: medical device reports filed with FDA

1,883 reports name it as the manufacturer of the device involved, 2013–2026.

1,883
reports naming it as manufacturer
0% of all MAUDE reports
229
reports, 12 months to August 2026
324 in the 12 months before
32%
classified as malfunction
62.3% across all reports
9%
classified as death, as reported
0.9% across all reports

1,883 medical device reports received by FDA give Bolton Medical as the manufacturer of the device involved, 0% of the MAUDE database, from August 2013 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

229 reports arrived in the 12 months to August 2026, down 29% from 324 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (58.7%), malfunction (32%) and death (9%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
TREO Abdominal Stent-Graft SystemSystem, endovascular graft, aortic aneurysm treatment7601303.2%
Relay Thoracic Stent-Graft With Plus Delivery SystemSystem, endovascular graft, aortic aneurysm treatment408015.7%
Relay Pro Thoracic Stent-Graft systemSystem, endovascular graft, aortic aneurysm treatment224359.8%
Relay Pro NBS Thoracic Stent-Graft SystemSystem, endovascular graft, aortic aneurysm treatment223709.1%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
MIHSystem, endovascular graft, aortic aneurysm treatment1,88299.9%
PFVSystem, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment10.1%

Reports by month, five years

02244Sep 2021: 7Oct 2021: 18Nov 2021: 9Dec 2021: 222022Jan 2022: 14Feb 2022: 18Mar 2022: 22Apr 2022: 16May 2022: 12Jun 2022: 18Jul 2022: 7Aug 2022: 28Sep 2022: 15Oct 2022: 17Nov 2022: 23Dec 2022: 232023Jan 2023: 21Feb 2023: 44Mar 2023: 22Apr 2023: 19May 2023: 30Jun 2023: 40Jul 2023: 22Aug 2023: 29Sep 2023: 26Oct 2023: 16Nov 2023: 31Dec 2023: 352024Jan 2024: 30Feb 2024: 30Mar 2024: 25Apr 2024: 17May 2024: 30Jun 2024: 34Jul 2024: 27Aug 2024: 35Sep 2024: 21Oct 2024: 28Nov 2024: 26Dec 2024: 432025Jan 2025: 22Feb 2025: 30Mar 2025: 36Apr 2025: 25May 2025: 22Jun 2025: 23Jul 2025: 23Aug 2025: 25Sep 2025: 26Oct 2025: 26Nov 2025: 26Dec 2025: 222026Jan 2026: 23Feb 2026: 18Mar 2026: 23Apr 2026: 18May 2026: 3Jun 2026: 11Jul 2026: 13Aug 2026: 20

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death9%169
Injury58.7%1,105
Malfunction32%603
Other0.3%5
Not given0.1%1

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Bolton Medical reports

How many FDA device reports name Bolton Medical as manufacturer?

1,883 reports through August 2026, 229 of them in the latest 12 months.

Which of its brands appear most often?

TREO Abdominal Stent-Graft System (760), Relay Thoracic Stent-Graft With Plus Delivery System (408), Relay Pro Thoracic Stent-Graft system (224) and Relay Pro NBS Thoracic Stent-Graft System (223).

Which device types does it report on?

system, endovascular graft, aortic aneurysm treatment (99.9%) and system, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment (0.1%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.